Tabula Rasa HealthCare, Inc.
Net SellingTRHC·US·🇺🇸 US
7%buys·93%sales
1,609 transactions$18.4MTotal buys·48 buys
$20124769.0BTotal sells·689 sells
3939 insiders
Last: Nov 7, 2023
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Nov 7, 23 | Indaba Capital Fund, L.P. | Sell | $492255864.4M | |
| Nov 7, 23 | IC GP, LLC | Sell | $492255864.4M | |
| Nov 7, 23 | Indaba Capital Management, LLC | Sell | $492255864.4M | |
| Nov 7, 23 | SCHRIER DEREK C | Sell | $492255864.4M | |
| Nov 6, 23 | Indaba Capital Fund, L.P. | Sell | $4538936250.0M | |
| Nov 6, 23 | IC GP, LLC | Sell | $4538936250.0M | |
| Nov 6, 23 | Indaba Capital Management, LLC | Sell | $4538936250.0M | |
| Nov 6, 23 | SCHRIER DEREK C | Sell | $4538936250.0M | |
| Nov 3, 23 | Beckwith Samira | Disposition | $1K | |
| Nov 3, 23 | Adams Brian W | Disposition | - |
Tabula Rasa HealthCare, Inc. is seeing coordinated insider selling. 4 insiders sold shares in the last 30 days, with total sell volume of $20124768.5B. Overall insider sentiment is bearish (93% sales).
Tabula Rasa HealthCare, Inc. (TRHC) has recorded 1 609 insider operations, including 48 open-market purchases ($18.4M), 689 sales ($20124769.0B) and 872 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (93% sales).
Tabula Rasa HealthCare, Inc. shows moderate insider activity with 5 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Knowlton Calvin H (CEO), Adams Brian W (CEO) & Cancro Thomas (CFO), with respectively 371, 98, 9 transactions.
Across all 1 609 recorded transactions, the breakdown by type is: sales (689, 43%), exercise (557, 35%), grant (180, 11%), disposition (52, 3%), buys (48, 3%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Tabula Rasa HealthCare, Inc. has recorded 1 609 insider operations in total, including 48 open-market purchases ($18.4M), 689 sales ($20124769.0B) and 872 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on November 7, 2023.
Insiders at Tabula Rasa HealthCare, Inc. are currently net sellers, with 7% purchases and 93% sales across all reported transactions. Total buy volume is $18.4M versus $20124769.0B in sales, indicating a bearish insider sentiment.
InsiderLens tracks 39 insiders at Tabula Rasa HealthCare, Inc. (TRHC). Knowlton Calvin H (CEO, 371 tx), Adams Brian W (CEO, 98 tx), Cancro Thomas (CFO, 9 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for TRHC is bearish, based on a 7% buy ratio across 737 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Tabula Rasa HealthCare, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.